Nicole Sonnert is a Senior Associate on Playground's engineered biology team, focusing on life sciences. She has a background in antibody discovery and a PhD from Yale, with venture capital experience from Canaan Partners.
At firms with a similar stage, sector and check size.
One email when Nicole's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckNicole Sonnert is a Senior Associate on Playground's engineered biology team, focusing on life sciences. She has a background in antibody discovery and a PhD from Yale, with venture capital experience from Canaan Partners.
Nicole Sonnert invests through Playground Global, which writes checks of $3M to $10M at seed, series a.
Email [email protected], the firm's inbox for founders, and name Nicole in the subject. A warm intro from a founder Playground Global backed works better.
Adimab, L.L.C.; fellow at Canaan Partners; Senior Associate at Playground; antibody discovery team member at Adimab, L.L.C.; associate at Playground.
Last updated 2026-10-15. Is this you? Ask for a correction.